Literature DB >> 3020233

Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.

J R Carstairs, P J Barnes.   

Abstract

Binding of [125I]vasoactive intestinal peptide (VIP) to human and guinea pig lung sections was characterized and VIP receptors localized by light-microscopic autoradiography. Inhibition of [125I] VIP binding by unlabeled VIP, peptide histidine isoleucine, peptide histidine methionine, secretin and VIP fragment VIP10-28 indicated that [125I]VIP bound to specific receptors and binding was shown to be reversible. Scatchard analysis showed two binding sites; human lung and a dissociation constant (Kd) of 0.27 +/- 0.04 and 23.3 +/- 3.5 nM, with maximum binding capacities (Bmax) of 11.2 +/- 3.1 and 589 +/- 98 fmol mg-1 of protein for the high and low affinity sites, respectively. Guinea pig lung similarly had a high affinity Kd of 0.3 +/- 0.05 nM and Bmax of 226 +/- 61.1 fmol mg-1 of protein and a low affinity Kd value of 18.8 +/- 2.4 nM and Bmax of 1730 +/- 260 fmol mg-1 of protein. In both human and guinea pig lung there was labeling of cellular structures and no specific labeling pattern was found in sections incubated in the presence of an excess of unlabeled VIP. A high density of labeling was found over airway epithelium of all airways, submucosal glands and vascular smooth muscle. There was also labeling of airway smooth muscle of large, but not of small, airways. This localization corresponds to the pattern of VIPergic innervation. In addition, there was labeling of alveolar walls. This indicates that VIP has a physiological role in the lung.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020233

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation.

Authors:  S G Farmer; J Togo
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

Review 2.  Airway receptors.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

3.  Regulatory peptides in the respiratory system.

Authors:  P J Barnes
Journal:  Experientia       Date:  1987-07-15

Review 4.  Gut endocrine and neural peptides.

Authors:  Anne E Bishop; Julia M Polak
Journal:  Endocr Pathol       Date:  1990-03       Impact factor: 3.943

Review 5.  The physiological roles of secretin and its receptor.

Authors:  Syeda Afroze; Fanyin Meng; Kendal Jensen; Kelly McDaniel; Kinan Rahal; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Shannon S Glaser
Journal:  Ann Transl Med       Date:  2013-10

6.  Vasoactive intestinal peptide in human nasal mucosa.

Authors:  J N Baraniuk; J D Lundgren; M Okayama; J Mullol; M Merida; J H Shelhamer; M A Kaliner
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Regul Pept       Date:  2010-06-08

8.  Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.

Authors:  G Ciabattoni; P Montuschi; D Currò; G Togna; P Preziosi
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

Review 9.  Peptides in the mammalian cardiovascular system.

Authors:  J Wharton; S Gulbenkian
Journal:  Experientia       Date:  1987-07-15

10.  Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.

Authors:  Renaud Dérand; Alicia Montoni; Laurence Bulteau-Pignoux; Thierry Janet; Bertrand Moreau; Jean-Marc Muller; Frédéric Becq
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.